Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Kevin A. Coleman"'
Autor:
Asli Muvaffak, Kevin G. Coleman
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundAtaxia telangiectasia-mutated (ATM) kinase is a central regulator of the DNA damage response (DDR) signaling pathway, and its function is critical for the maintenance of genomic stability in cells that coordinate a network of cellular proce
Externí odkaz:
https://doaj.org/article/25bed31213ed4a50acfbdf2081992ecd
Autor:
Karen A. Simon-Crevatis, Shailesh R. Metkar, Justin T. Hardcastle, Keith Jansson, Usman Shabon, Rajarshi Choudhury, Euan A. Stronach, Kevin G. Coleman, Asli Muvaffak
Publikováno v:
Cancer Research. 83:6175-6175
While cyclin dependent kinases (CDKs) were originally implicated in cell cycle regulation, several CDKs including CDK7, CDK8, and CDK9 play critical roles in transcription through regulation of RNA polymerase II (Pol II) activity. In addition to expe
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e28022 (2011)
Although G-protein coupled receptors (GPCRs) are a common element in many chemosensory transduction pathways in eukaryotic cells, no GPCR or regulated G-protein activity has yet been shown in any ciliate. To study the possible role for a GPCR in the
Externí odkaz:
https://doaj.org/article/95d378cfa44f4b8786aa80071bbb1727
Autor:
Nathaniel L. Elsen, Zangwei Xu, Peter J. Dandliker, Peter Saradjian, Keith W. Rickert, Berengere Sauvagnat, Nadya Smotrov, Dawn L. Hall, Elliott B. Nickbarg, Yiping Chen, Sujata Sharma, Kevin J. Lumb, Maria Kornienko, Noel Byrne, Chad Chamberlin, Christine Andrews, Samantha J Allen, Ilona Kariv, Jennifer M. Shipman, Patrick J. Curran, Kevin G. Coleman, Beutel Bruce A, Rachael E. Ford, Victoria Kutilek, Andrew Hashke, Rafael Fernandez, Tianxiao Sun, Matthew Richards, Ryan Boinay
Publikováno v:
SLAS Discovery. 21:608-619
The primary objective of early drug discovery is to associate druggable target space with a desired phenotype. The inability to efficiently associate these often leads to failure early in the drug discovery process. In this proof-of-concept study, th
Autor:
Asli Muvaffak, Kevin G. Coleman
Publikováno v:
Cancer Research. 80:2379-2379
PARP inhibitors have transformed the treatment for ovarian cancer, which is known to have high incidence of homologous recombination (HR) deficiency through the loss of BRCA1 or BRCA2 genes. 30-35% of ovarian cancer patients have defects in BRCA1/2 g
Autor:
Vanna M Dickerson, Corey F. Saba, Karen K. Cornell, MaryAnn G. Radlinsky, Morika Ogawa, Chad W. Schmiedt, Kevin D. Coleman
Publikováno v:
Journal of the American Veterinary Medical Association. 247:786-792
Objective—To evaluate outcomes of dogs and owner satisfaction and perception of their dogs’ adaptation following amputation of a thoracic or pelvic limb. Design—Retrospective case series. Animals—64 client-owned dogs. Procedures—Medical rec
Publikováno v:
Clinical Practice in Pediatric Psychology. 3:218-224
Publikováno v:
Veterinary Surgery. 44:613-626
Objective To provide (1) a comprehensive description of hemipelvectomy; and (2) report clinical application and outcome of hemipelvectomy in dogs and cats. Study Design Descriptive report and retrospective case series. Animals Dogs (n = 4) and 5 cats
Autor:
Jing Ju Wang, Sarah Wang, Bin Feng, Kevin G. Coleman, Yinghui Zhou, Asli Muvaffak, Sridhar Ramaswamy
Publikováno v:
Molecular Cancer Therapeutics. 18:A091-A091
Non-Small Cell Lung Cancer (NSCLC) is the leading cause of cancer related mortality worldwide, and accounts for 80-85% of all lung cancer diagnoses. While targeted therapies against epidermal growth factor receptor (EGFR) mutations and anaplastic lym
Autor:
Johanna K. Kaufmann, Brianna Flynn, Kevin Morse, Maria C. Speranza, Jing Zhou, Sridhar Ramaswamy, Sean Mackay, Kevin G. Coleman
Publikováno v:
Cancer Research. 79:3242-3242
Co-expression of immune checkpoint receptors (ICRs) PD-1, TIM-3, and LAG-3 characterizes chronically activated and exhausted tumor-infiltrating T cells (TILs), suggesting their targeting may have applicability for the treatment of multiple cancer typ